These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 37236021)

  • 1. Novel drug-like fluorenyl derivatives as selective butyrylcholinesterase and β-amyloid inhibitors for the treatment of Alzheimer's disease.
    Pasieka A; Panek D; Zaręba P; Sługocka E; Gucwa N; Espargaró A; Latacz G; Khan N; Bucki A; Sabaté R; Więckowska A; Malawska B
    Bioorg Med Chem; 2023 Jun; 88-89():117333. PubMed ID: 37236021
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discovery of novel multifunctional ligands targeting GABA transporters, butyrylcholinesterase, β-secretase, and amyloid β aggregation as potential treatment of Alzheimer's disease.
    Zaręba P; Łątka K; Mazur G; Gryzło B; Pasieka A; Godyń J; Panek D; Skrzypczak-Wiercioch A; Höfner GC; Latacz G; Maj M; Espargaró A; Sabaté R; Jóźwiak K; Wanner KT; Sałat K; Malawska B; Kulig K; Bajda M
    Eur J Med Chem; 2023 Dec; 261():115832. PubMed ID: 37837674
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure-activity relationship studies of benzyl-, phenethyl-, and pyridyl-substituted tetrahydroacridin-9-amines as multitargeting agents to treat Alzheimer's disease.
    Osman W; Mohamed T; Sit VM; Vasefi MS; Beazely MA; Rao PP
    Chem Biol Drug Des; 2016 Nov; 88(5):710-723. PubMed ID: 27282589
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design, synthesis and biological activity of novel tacrine-isatin Schiff base hybrid derivatives.
    Riazimontazer E; Sadeghpour H; Nadri H; Sakhteman A; Tüylü Küçükkılınç T; Miri R; Edraki N
    Bioorg Chem; 2019 Aug; 89():103006. PubMed ID: 31158577
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design, synthesis, and biological evaluation of novel tryptanthrin derivatives as selective acetylcholinesterase inhibitors for the treatment of Alzheimer's disease.
    Xia J; Dong S; Yang L; Wang F; Xing S; Du J; Li Z
    Bioorg Chem; 2024 Feb; 143():106980. PubMed ID: 38006789
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 1-Benzylpyrrolidine-3-amine-based BuChE inhibitors with anti-aggregating, antioxidant and metal-chelating properties as multifunctional agents against Alzheimer's disease.
    Wichur T; Więckowska A; Więckowski K; Godyń J; Jończyk J; Valdivieso ÁDR; Panek D; Pasieka A; Sabaté R; Knez D; Gobec S; Malawska B
    Eur J Med Chem; 2020 Feb; 187():111916. PubMed ID: 31812794
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design, Synthesis, and Biological Evaluation of 1-Benzylamino-2-hydroxyalkyl Derivatives as New Potential Disease-Modifying Multifunctional Anti-Alzheimer's Agents.
    Panek D; Więckowska A; Jończyk J; Godyń J; Bajda M; Wichur T; Pasieka A; Knez D; Pišlar A; Korabecny J; Soukup O; Sepsova V; Sabaté R; Kos J; Gobec S; Malawska B
    ACS Chem Neurosci; 2018 May; 9(5):1074-1094. PubMed ID: 29345897
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design, synthesis and biological evaluation of novel deoxyvasicinone-indole as multi-target agents for Alzheimer's disease.
    Nerella A; Jeripothula M
    Bioorg Med Chem Lett; 2021 Oct; 49():128212. PubMed ID: 34153471
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dual targeting of cholinesterase and amyloid beta with pyridinium/isoquinolium derivatives.
    Chakravarty H; Ju Y; Chen WH; Tam KY
    Drug Dev Res; 2020 Apr; 81(2):242-255. PubMed ID: 31837041
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multifunctional novel Diallyl disulfide (DADS) derivatives with β-amyloid-reducing, cholinergic, antioxidant and metal chelating properties for the treatment of Alzheimer's disease.
    Manral A; Saini V; Meena P; Tiwari M
    Bioorg Med Chem; 2015 Oct; 23(19):6389-403. PubMed ID: 26337018
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discovery of multifunctional anti-Alzheimer's agents with a unique mechanism of action including inhibition of the enzyme butyrylcholinesterase and γ-aminobutyric acid transporters.
    Pasieka A; Panek D; Jończyk J; Godyń J; Szałaj N; Latacz G; Tabor J; Mezeiova E; Chantegreil F; Dias J; Knez D; Lu J; Pi R; Korabecny J; Brazzolotto X; Gobec S; Höfner G; Wanner K; Więckowska A; Malawska B
    Eur J Med Chem; 2021 Jun; 218():113397. PubMed ID: 33838585
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tetrahydroacridine derivatives with dichloronicotinic acid moiety as attractive, multipotent agents for Alzheimer's disease treatment.
    Czarnecka K; Chufarova N; Halczuk K; Maciejewska K; Girek M; Skibiński R; Jończyk J; Bajda M; Kabziński J; Majsterek I; Szymański P
    Eur J Med Chem; 2018 Feb; 145():760-769. PubMed ID: 29353726
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discovery and Biological Evaluation of New Selective Acetylcholinesterase Inhibitors with Anti-Aβ Aggregation Activity through Molecular Docking-Based Virtual Screening.
    Liu G; Jiao Y; Lin Y; Hao H; Dou Y; Yang J; Jiang CS; Chang P
    Chem Pharm Bull (Tokyo); 2020 Feb; 68(2):161-166. PubMed ID: 31813907
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biological evaluation of synthetic α,β-unsaturated carbonyl based cyclohexanone derivatives as neuroprotective novel inhibitors of acetylcholinesterase, butyrylcholinesterase and amyloid-β aggregation.
    Zha GF; Zhang CP; Qin HL; Jantan I; Sher M; Amjad MW; Hussain MA; Hussain Z; Bukhari SN
    Bioorg Med Chem; 2016 May; 24(10):2352-9. PubMed ID: 27083471
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel anti-neuroinflammatory pyranone-carbamate derivatives as selective butyrylcholinesterase inhibitors for treating Alzheimer's disease.
    Yu C; Liu X; Ma B; Xu J; Chen Y; Dai C; Peng H; Zha D
    J Enzyme Inhib Med Chem; 2024 Dec; 39(1):2313682. PubMed ID: 38362862
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design, synthesis and evaluation of novel tacrine-(β-carboline) hybrids as multifunctional agents for the treatment of Alzheimer's disease.
    Lan JS; Xie SS; Li SY; Pan LF; Wang XB; Kong LY
    Bioorg Med Chem; 2014 Nov; 22(21):6089-104. PubMed ID: 25282654
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New phosphazine and phosphazide derivatives as multifunctional ligands targeting acetylcholinesterase and β-Amyloid aggregation for treatment of Alzheimer's disease.
    El-Sayed NF; El-Hussieny M; Ewies EF; Fouad MA; Boulos LS
    Bioorg Chem; 2020 Jan; 95():103499. PubMed ID: 31838287
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Imino-2H-Chromene Based Derivatives as Potential Anti-Alzheimer's Agents: Design, Synthesis, Biological Evaluation and in Silico Study.
    Attarroshan M; Firuzi O; Iraji A; Sharifi S; Tavakkoli M; Vesal M; Khoshneviszadeh M; Pirhadi S; Edraki N
    Chem Biodivers; 2022 Jan; 19(1):e202100599. PubMed ID: 34786830
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New tacrine-acridine hybrids as promising multifunctional drugs for potential treatment of Alzheimer's disease.
    Chufarova N; Czarnecka K; Skibiński R; Cuchra M; Majsterek I; Szymański P
    Arch Pharm (Weinheim); 2018 Jul; 351(7):e1800050. PubMed ID: 29870588
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design, synthesis and biological activity of 1H-indene-2-carboxamides as multi-targeted anti-Alzheimer agents.
    Koca M; Yerdelen KO; Anil B; Kasap Z; Sevindik H; Ozyurek I; Gunesacar G; Turkaydin K
    J Enzyme Inhib Med Chem; 2016; 31(sup2):13-23. PubMed ID: 27226239
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.